Pluristyx
PrivateLast Round
Series A
Jul 13, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pluristyx is a biotechnology company that provides induced pluripotent stem cell (iPSC) products, contract development, and manufacturing services to accelerate the development of cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pluristyx Comparables
Compare Pluristyx with similar companies based on industry and business-model similarity.
Pluristyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 13, 2026 | ||||
| Grant | Nov 17, 2025 | ||||
| Convertible Debt | Jul 28, 2025 | ||||
| Early Funding | Dec 21, 2023 |
Key People
Founding team and executive leadership
Pluristyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JDRF | Grant |
| BroadOak Capital Partners | Convertible Debt, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Raised $10M in Series A funding.
- Apr 19, 2026
Monthly visitors grew 97% MoM, reaching 3.7K.
Pluristyx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pluristyx's valuation, stock price, and market status.